STBCi095-A

BPC339-03-01

iPSC line

At European Collection of Authenticated Cell Cultures (ECACC)
A CLIP contains information about a cell line including any specific third party obligations relating to, for example, licensing obligations or the donor consent which affect the use of the cell line.
A batch specific Certificate of Analysis will be available to download once you receive your EBiSC iPSC line.

General#

Cell Line

hPSCreg Name STBCi095-A
Alternative name(s)
BPC339-03-01
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
UKKi008-A
(NP0016-3)
Donor's gene variants:
SCN5A
Donor diseases:
Prolonged QT interval
UKKi011-A
(NP0040-8)
UKKi012-A
(NP0041-17, NP0041)
UNEWi004-A
(PRPF31 SH)
Donor's gene variants:
PRPF31
Donor diseases:
Retinitis pigmentosa
UNEWi005-A
(PRPF31 RH)
Donor's gene variants:
PRPF31
Donor diseases:
Retinitis pigmentosa
UKBi002-A
(iLB-C2-36m-r2)
UKBi003-A
(iLB-MJD1-32m-r9, LB-32-r9)
Donor's gene variants:
ATXN3, ATXN3
Donor diseases:
Spinocerebellar ataxia type 3
UKBi004-A
(LB-30-12, iLB-C1-30m-r12)
UKBi006-A
(iLB-C-35m-r1, LB-35-1)
UKBi008-A
(iLB-MJD4-34m-r1, LB-34-1)
Donor's gene variants:
ATXN3, ATXN3
Donor diseases:
Spinocerebellar ataxia type 3
WTSIi002-A
(HPSI0913i-eika_2)
WTSIi004-A
(HPSI1113i-qolg_3)
WTSIi006-A
(HPSI1113i-hayt_1)
WTSIi008-A
(HPSI1013i-kuxp_1)
WTSIi010-A
(HPSI0314i-xugn_1)
WTSIi013-A
(HPSI0214i-kucg_2)
WTSIi014-A
(HPSI0214i-heja_2)
WTSIi016-A
(HPSI0114i-oevr_3)
WTSIi018-A
(HPSI0114i-kolf_3)
WTSIi019-A
(HPSI0114i-iisa_3)
BIONi010-A
(K1P53)
BIONi010-B
(K2P53, BIONi010-B)
BIONi010-C
(BIONi010-C, K3P53)
RBi001-A
(fb101, RB101)
WTSIi022-A
(HPSI1013i-yemz_1)
WTSIi023-A
(HPSI0114i-zapk_3)
WTSIi025-A
(HPSI1013i-pamv_1)
WTSIi031-A
(HPSI0314i-bipt_1)
WTSIi032-A
(HPSI1113i-bima_1)
UNEWi019-A
Donor diseases:
anemia
HUBi001-A
(HUB001Ai)
WTSIi039-A
(HPSI1013i-wopl_1)
WTSIi042-A
(HPSI1013i-jufd_2)
WTSIi014-B
(HPSI0214i-heja_1)
WTSIi010-B
(HPSI0314i-xugn_2)
WTSIi025-B
(HPSI1013i-pamv_3)
WTSIi004-B
(HPSI1113i-qolg_1)
WTSIi022-B
(HPSI1013i-yemz_3)
WTSIi006-B
(HPSI1113i-hayt_3)
UCLi001-A
(HHItC9S-V19)
Donor's gene variants:
C9orf72
Donor diseases:
Frontotemporal dementia
UCLi002-A
(HHItC9D-V34, DN19)
Donor's gene variants:
C9orf72, C9orf72
Donor diseases:
Frontotemporal dementia
WTSIi019-B
(HPSI0114i-iisa_1)
WTSIi050-A
(HPSI1014i-toss_3)
WTSIi051-A
(HPSI1113i-uofv_1)
WTSIi053-A
(HPSI0413i-corn_1)
WTSIi054-A
(HPSI0413i-nudd_1)
WTSIi064-A
(HPSI0613i-bohf_1)
WTSIi065-A
(HPSI0613i-eojr_2)

Provider

Depositor StemBANCC (STBC)
Distributors
EBiSC
European Collection of Authenticated Cell Cultures (ECACC)

External Databases

hPSCreg STBCi095-A
BioSamples SAMEA104493907
ECACC 66540870
Cellosaurus CVCL_RD60
Wikidata Q54970229
CLO CLO_0104808

General Information

* Is the cell line readily obtainable for third parties?
Yes
Research use: allowed
Clinical use: not allowed
Commercial use: not allowed

Donor Information#

General Donor Information

Sex male

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
drug-induced liver injury (primary disease)
Synonyms
  • Liver Injury, Drug-Induced
  • Drug-Induced Liver Disease
  • Toxic Hepatitis
  • Hepatitis, Toxic
  • Hepatitis, Drug-Induced
  • drug-induced liver injury
  • drug-induced disorder of liver
  • drug induced hepatotoxicity
show more synonyms

External Databases (Donor)

BioSamples SAMEA104493908

hIPSC Derivation#

General

Source cell type
erythroblast
A nucleated precursor of an erythrocyte that lacks hematopoietic lineage markers.
Source cell type (free text) PBMC erythroblasts

Reprogramming method

Vector type Non-integrating
Vector Sendai virus

Vector free reprogramming

Other

Derived under xeno-free conditions
Unknown
Derived under GMP?
Unknown
Available as clinical grade?
Unknown

Culture Conditions#

The following are the depositor culture conditions, they do not refer to any specific batch.
Surface coating Matrigel/Geltrex
Feeder cells
No
Passage method Enzyme-free cell dissociation
EDTA
O2 Concentration 21 %
CO2 Concentration 5 %
Medium mTeSR™ 1

Characterisation#

Differentiation Potency

Microbiology / Virus Screening

HIV 1 Negative
Hepatitis B Negative
Hepatitis C Negative
Mycoplasma Negative

Genotyping#

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
No abnormalities detected
Karyotyping method: Molecular karyotyping by SNP array
http://

Other Genotyping (Cell Line)